open access

Vol 81, No 12 (2010)
ARTICLES
Get Citation

Positive correlation between serum omentin and thrombospondin-1 in gestational diabetes despite lack of correlation with insulin resistance indices

Krzysztof Lewandowski, Iwona Nadel, Andrzej Lewiński, Małgorzata Bienkiewicz, B. Tan, Harpal S. Randeva, Katarzyna Cypryk
Ginekol Pol 2010;81(12).

open access

Vol 81, No 12 (2010)
ARTICLES

Abstract

Gestational Diabetes (GDM) is characterized by insulin resistance and a pro-inflammatory state, both factors possible related to adipokine expression. Subjects and Methods: The study included 20 women with GDM, diagnosed according to the WHO criteria, and 23 matched for age and BMI women with normal glucose tolerance. Omentin and TSP-1 were measured by ELISA assays. Insulin resistance was assessed by HOMA and Insulin Resistance Index (IRI). Results: There were no significant differences in omentin and TSP-1 levels between subjects with GDM and controls (48.0±12.0ng/ml versus 50.2±7.9ng/ml and 2150±1661ng/ml versus 1569±1160ng/ml, p=0.64 and p=0.29, for omentin and TSP-1 in GDM and control subjects, respectively). There was no significant correlation between either omentin or TSP-1 with HOMA or IRI, however, there was a significant positive correlation between thrombospondin-1 and omentin (r=0.49, p=0.010). There was also a positive correlation between serum omentin and glucose levels at 60 and 90 minutes of OGTT, however, in the control group only (p<0.05). Conclusions: Concentrations of omentin and thrombospondin-1 seem to be inter-related in pregnancy, however, there are no differences in serum levels between women with normal glucose tolerance and those with glucose intolerance. These observations suggest that regulation of concentrations of these adipokines in pregnancy might be mediated though different mechanisms than in non-pregnant subjects.

Abstract

Gestational Diabetes (GDM) is characterized by insulin resistance and a pro-inflammatory state, both factors possible related to adipokine expression. Subjects and Methods: The study included 20 women with GDM, diagnosed according to the WHO criteria, and 23 matched for age and BMI women with normal glucose tolerance. Omentin and TSP-1 were measured by ELISA assays. Insulin resistance was assessed by HOMA and Insulin Resistance Index (IRI). Results: There were no significant differences in omentin and TSP-1 levels between subjects with GDM and controls (48.0±12.0ng/ml versus 50.2±7.9ng/ml and 2150±1661ng/ml versus 1569±1160ng/ml, p=0.64 and p=0.29, for omentin and TSP-1 in GDM and control subjects, respectively). There was no significant correlation between either omentin or TSP-1 with HOMA or IRI, however, there was a significant positive correlation between thrombospondin-1 and omentin (r=0.49, p=0.010). There was also a positive correlation between serum omentin and glucose levels at 60 and 90 minutes of OGTT, however, in the control group only (p<0.05). Conclusions: Concentrations of omentin and thrombospondin-1 seem to be inter-related in pregnancy, however, there are no differences in serum levels between women with normal glucose tolerance and those with glucose intolerance. These observations suggest that regulation of concentrations of these adipokines in pregnancy might be mediated though different mechanisms than in non-pregnant subjects.
Get Citation

Keywords

omentin, thrombospondin 1, gestational diabetes, insulin resistance

About this article
Title

Positive correlation between serum omentin and thrombospondin-1 in gestational diabetes despite lack of correlation with insulin resistance indices

Journal

Ginekologia Polska

Issue

Vol 81, No 12 (2010)

Bibliographic record

Ginekol Pol 2010;81(12).

Keywords

omentin
thrombospondin 1
gestational diabetes
insulin resistance

Authors

Krzysztof Lewandowski
Iwona Nadel
Andrzej Lewiński
Małgorzata Bienkiewicz
B. Tan
Harpal S. Randeva
Katarzyna Cypryk

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl